Grifols, S.A. - American Depositary Shares (GRFS)
8.7100
+0.4400 (5.32%)
Grifols S.A. is a global healthcare company that specializes in the development, production, and marketing of plasma-derived therapies and other innovative healthcare solutions
The company focuses on treating a variety of health conditions, including immune deficiencies, hemophilia, and other chronic diseases, by harnessing the therapeutic potential of human plasma. Grifols is also involved in the manufacture of diagnostic tools and systems, contributing to improved patient care and disease management. With a commitment to research and development, Grifols aims to advance the field of medicine through cutting-edge technologies and a robust portfolio of life-saving products.
Previous Close | 8.270 |
---|---|
Open | 8.670 |
Bid | 8.700 |
Ask | 8.710 |
Day's Range | 8.620 - 8.780 |
52 Week Range | 5.300 - 9.960 |
Volume | 711,825 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,145,953 |
News & Press Releases

Via Benzinga · November 29, 2024

Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial stability in 2024.
Via Benzinga · November 29, 2024

Via Benzinga · November 27, 2024

Via Benzinga · November 27, 2024

Via Benzinga · November 27, 2024

Via Benzinga · November 19, 2024

Via Benzinga · November 19, 2024

Via Benzinga · September 24, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 31, 2024
INVESTIGATION ALERT: Grifols SA Faces Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - August 31, 2024 - Kaplan Fox & Kilsheimer LLP continues to investigate potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · August 31, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 29, 2024
Grifols SA is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - August 29, 2024 - Kaplan Fox & Kilsheimer LLP continues to investigate potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · August 29, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 27, 2024
Grifols SA Investors are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
NEW YORK, NY - (NewMediaWire) - August 27, 2024 - Kaplan Fox & Kilsheimer LLP continues to investigate potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · August 27, 2024

Via Benzinga · August 25, 2024

Via Benzinga · August 22, 2024

Brookfield Asset Management is reportedly pursuing €9.5 billion in debt financing for a potential take-private deal for Grifols. The deal could lead to major financial restructuring, impacting bondholders and shareholders amid scrutiny of Grifols' high debt levels and credit downgrades.
Via Benzinga · August 21, 2024

Hagens Berman urges investors in Grifols, S.A. American Depositary Shares (NASDAQGRFS) who suffered substantial losses to submit your losses now.
By Hagens Berman · Via Business Wire · August 2, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · August 2, 2024
GRFS Is Being Investigated for Potential Securities Law Violations Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - (NewMediaWire) - August 02, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · August 2, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 31, 2024
Kaplan Fox & Kilsheimer LLP is Investigating Possible Securities Law Violations against Grifols SA (GRFS)
NEW YORK, NY - (NewMediaWire) - July 31, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · July 31, 2024

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · July 30, 2024
Kaplan Fox & Kilsheimer LLP is Investigating Grifols SA (GRFS) for Potential Securities Law Violations
NEW YORK, NY - (NewMediaWire) - July 30, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Grifols SA (GRFS) (“Grifols” or the “Company”) (NASDAQGRFS).
Via TheNewswire.com · July 30, 2024